2.13 USD
▲-0.01+0.95%
盘后 2.15 +1.90%
2026-08-03
市值
$17.56M
市盈率
—
EPS
-1.97
股息率
—
52 周区间
1.81 – 12.37
成交量
131.36K
Beta
0.44
目标价
6.00
52W 低 1.8152W 高 12.37
价格走势
公司简介
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. It also develops LPCN 1154 (BRLIZIO), an oral neuro-steroid in a Phase 3 pivotal trial for postpartum depression; LPCN 1148, a prodrug of testosterone and testosterone laurate that has completed a Phase 2 trial for the management of decompensated cirrhosis; LPCN 1107, an...